A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer Patients
Not yet recruiting
- Conditions
- Metastatic Breast Cancer (MBC)
- First Posted Date
- 2025-02-19
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- Menarini Silicon Biosystems, INC
- Target Recruit Count
- 187
- Registration Number
- NCT06833853
- Locations
- 🇺🇸
UPMC Magee Womens Hospital, Pittsburgh, Pennsylvania, United States
ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC)
Active, not recruiting
- Conditions
- Metastatic Breast Cancer
- First Posted Date
- 2022-12-22
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Menarini Silicon Biosystems, INC
- Target Recruit Count
- 65
- Registration Number
- NCT05662345
- Locations
- 🇺🇸
Mayo Clinic Health System Albert Lea, Albert Lea, Minnesota, United States
🇺🇸Mayo Clinic Health System Mankato, Mankato, Minnesota, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath